Dr. Gotabhaya Ranasinghe speaks with Professor Roger, a leading global health expert and chief investigator of the GMR-2 polypill study, about a new low-dose triple combination pill poised to transform hypertension care. The pill combining telmisartan, amlodipine, and indapamide delivers stronger, faster blood pressure control with minimal side effects, supporting better adherence and long-term outcomes. With Sri Lanka playing a major role in the research and the formulation already approved by the FDA, the discussion highlights its potential to significantly reduce the country’s burden of high blood pressure, stroke, and heart disease.
